These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 32303303)
1. Detection and Pharmacokinetics of Etoricoxib in Thoroughbred Horses. Subhahar MB; Singh J; Albert PH; Kadry AM J Equine Vet Sci; 2020 May; 88():102942. PubMed ID: 32303303 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics, metabolism and excretion of celecoxib, a selective cyclooxygenase-2 inhibitor, in horses. Subhahar MB; Singh J; Albert PH; Kadry AM J Vet Pharmacol Ther; 2019 Sep; 42(5):518-524. PubMed ID: 30888074 [TBL] [Abstract][Full Text] [Related]
3. Absorption, metabolism, and excretion of etoricoxib, a potent and selective cyclooxygenase-2 inhibitor, in healthy male volunteers. Rodrigues AD; Halpin RA; Geer LA; Cui D; Woolf EJ; Matthews CZ; Gottesdiener KM; Larson PJ; Lasseter KC; Agrawal NG Drug Metab Dispos; 2003 Feb; 31(2):224-32. PubMed ID: 12527704 [TBL] [Abstract][Full Text] [Related]
4. Single- and multiple-dose pharmacokinetics of etoricoxib, a selective inhibitor of cyclooxygenase-2, in man. Agrawal NG; Porras AG; Matthews CZ; Rose MJ; Woolf EJ; Musser BJ; Dynder AL; Mazina KE; Lasseter KC; Hunt TL; Schwartz JI; McCrea JB; Gottesdiener KM J Clin Pharmacol; 2003 Mar; 43(3):268-76. PubMed ID: 12638395 [TBL] [Abstract][Full Text] [Related]
5. Dose proportionality of oral etoricoxib, a highly selective cyclooxygenase-2 inhibitor, in healthy volunteers. Agrawal NG; Porras AG; Matthews CZ; Woolf EJ; Miller JL; Mukhopadhyay S; Neu DC; Gottesdiener KM J Clin Pharmacol; 2001 Oct; 41(10):1106-10. PubMed ID: 11583479 [TBL] [Abstract][Full Text] [Related]
7. In vitro metabolism considerations, including activity testing of metabolites, in the discovery and selection of the COX-2 inhibitor etoricoxib (MK-0663). Chauret N; Yergey JA; Brideau C; Friesen RW; Mancini J; Riendeau D; Silva J; Styhler A; Trimble LA; Nicoll-Griffith DA Bioorg Med Chem Lett; 2001 Apr; 11(8):1059-62. PubMed ID: 11327589 [TBL] [Abstract][Full Text] [Related]
8. Detection and pharmacokinetics of grapiprant following oral administration to exercised Thoroughbred horses. Knych HK; Seminoff K; McKemie DS Drug Test Anal; 2018 Mar; ():. PubMed ID: 29575649 [TBL] [Abstract][Full Text] [Related]
9. Effects of etoricoxib on the pharmacokinetics of phenytoin. Medhi B; Sukhija M; Prakash A; Gaikwad S; Bansal V; Pandhi P Pharmacol Rep; 2008; 60(2):233-7. PubMed ID: 18443385 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of triamcinolone acetonide following intramuscular and intra-articular administration to exercised Thoroughbred horses. Knych HK; Vidal MA; Casbeer HC; McKemie DS Equine Vet J; 2013 Nov; 45(6):715-20. PubMed ID: 23574452 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of betamethasone in plasma, urine, and synovial fluid following intra-articular administration to exercised thoroughbred horses. Knych HK; Stanley SD; Harrison LM; Mckemie DS Drug Test Anal; 2017 Sep; 9(9):1385-1391. PubMed ID: 28117560 [TBL] [Abstract][Full Text] [Related]
12. Single dose oral etoricoxib for acute postoperative pain in adults. Clarke R; Derry S; Moore RA Cochrane Database Syst Rev; 2012 Apr; (4):CD004309. PubMed ID: 22513922 [TBL] [Abstract][Full Text] [Related]
13. Metabolism and excretion of imrecoxib in rat. Xu H; Zhang Y; Sun Y; Zhang P; Chu F; Guo Z; Zhang H; Zhong D Xenobiotica; 2006 May; 36(5):441-55. PubMed ID: 16854781 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of dextromethorphan and its metabolites in horses following a single oral administration. Corado CR; McKemie DS; Knych HK Drug Test Anal; 2017 Jun; 9(6):880-887. PubMed ID: 27580591 [TBL] [Abstract][Full Text] [Related]
15. Etoricoxib in acute pain associated with dental surgery: a randomized, double-blind, placebo- and active comparator-controlled dose-ranging study. Malmstrom K; Sapre A; Couglin H; Agrawal NG; Mazenko RS; Fricke JR Clin Ther; 2004 May; 26(5):667-79. PubMed ID: 15220011 [TBL] [Abstract][Full Text] [Related]
16. Role of human liver cytochrome P4503A in the metabolism of etoricoxib, a novel cyclooxygenase-2 selective inhibitor. Kassahun K; McIntosh IS; Shou M; Walsh DJ; Rodeheffer C; Slaughter DE; Geer LA; Halpin RA; Agrawal N; Rodrigues AD Drug Metab Dispos; 2001 Jun; 29(6):813-20. PubMed ID: 11353749 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and metabolism of orally administered firocoxib, a novel second generation coxib, in horses. Kvaternick V; Pollmeier M; Fischer J; Hanson PD J Vet Pharmacol Ther; 2007 Jun; 30(3):208-17. PubMed ID: 17472652 [TBL] [Abstract][Full Text] [Related]
18. Re-evaluation of the pharmacokinetics of xylazine administered to Thoroughbred horses. Habershon-Butcher J; Cutler C; Viljanto M; Hincks PR; Biddle S; Paine SW J Vet Pharmacol Ther; 2020 Jan; 43(1):6-12. PubMed ID: 31652007 [TBL] [Abstract][Full Text] [Related]
19. Determination of grapiprant plasma and urine concentrations in horses. Cox S; Sommardahl C; Fortner C; Davis R; Bergman J; Doherty T Vet Anaesth Analg; 2020 Sep; 47(5):705-709. PubMed ID: 32439238 [TBL] [Abstract][Full Text] [Related]
20. Effect of etoricoxib, a cyclooxygenase-2 selective inhibitor on aberrant crypt formation and apoptosis in 1,2 dimethyl hydrazine induced colon carcinogenesis in rat model. Sharma P; Kaur J; Sanyal SN Nutr Hosp; 2010; 25(1):39-48. PubMed ID: 20204254 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]